Advanced Cell's Robert Lanza, M.D. Will Speak on 'Promise: The Future of Stem Cells' Wednesday, March 28, 2007 at 7:30 PM at Quinnipiac University in Hamden, CT, Presented by StemConn 2007.ALAMEDA, Calif. -- Advanced Cell Technology, Inc.'s (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : ACTC ACTC Apple Certified Technical Coordinator ACTC Almaden Cycle Touring Club ACTC Associated Colleges of the Twin Cities ACTC All Ceylon Tamil Congress (Sri Lanka) ACTC Association Canadienne de Télévision par Câble ) Robert Lanza Robert Lanza is is Chief Scientific Officer Advanced Cell Technology (ACT) and Adjunct Professor at the Institute for Regenerative Medicine, Wake Forest University School of Medicine [1]. Lanza received both BA and MD degrees from the University of Pennsylvania. , M.D., VP of Research and Scientific Development, will participate in a panel discussion titled, "Promise: The Future of Stem Cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. Research," March 28, 2007 at 7:30 PM, at Quinnipiac University Quinnipiac University is a private four-year university in Hamden, Connecticut, located on about 500 acres (2 km²), just north of New Haven. The campus is situated at the foot of Sleeping Giant State Park. in Hamden, CT. The televised public forum, being presented by StemConn 2007, is for general audiences and focuses on the key issues that surround stem cell research. The panel discussion will be held in the Mancheski Executive Seminar Room, located in the Lender School of Business. For more information regarding StemConn 2007 including a complete program guide of the two-day event being held March 27-28, 2007, log on to http://stemconn.org/program.htm. About Advanced Cell Technology, Inc. Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell Embryonic stem cells (ES cells) are stem cells derived from the inner cell mass of an early stage embryo known as a blastocyst. Human embryos reach the blastocyst stage 4-5 days post fertilization, at which time they consist of 50-150 cells. ES cells are pluripotent. technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California Alameda is a city in Alameda County, California, United States. It is located on a small island of the same name next to Oakland, California in the San Francisco Bay. An additional part of the city is Bay Farm Island, which is adjacent to the Oakland International Airport. and Worcester, Massachusetts. For more information about the company, please visit http://www.advancedcell.com. Forward-Looking Statements Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the Annual Report on Form 10-KSB for the year ended December 31, 2006. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion